BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16123848)

  • 1. Effectiveness and determinants of the long-term beta intracoronary brachytherapy results.
    Witkowski A; Kalińczuk Ł; Chmielak Z; Łyczek J; Pregowski J; Kawczyńska M; Bulski W; Kulik A; Kepka C; Kruk M; Pszona S; Rózyłło W
    Kardiol Pol; 2005 Jun; 62(6):545-557; discussion 558. PubMed ID: 16123848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing a best-treatment strategy with intracoronary brachytherapy for in-stent restenosis in patients at high risk for recurrence.
    Kuiper KK; Salem M; Rotevatn S; Mills J; Nordrehaug JE
    Cardiovasc Revasc Med; 2007; 8(1):9-14. PubMed ID: 17293263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy.
    Wöhrle J; Krause BJ; Nusser T; Kochs M; Höher M
    Cardiovasc Revasc Med; 2006; 7(1):2-6. PubMed ID: 16513516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy.
    Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Neri S; Bunkheila F; Lombardo E; Pini S; Marrozzini C; Palmerini T; Taglieri N; Sbarzaglia P; Reggiani ML; Barbieri E; Branzi A
    Catheter Cardiovasc Interv; 2004 Dec; 63(4):433-8. PubMed ID: 15558757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-radiation therapy for long lesions in native coronary vessels: a matched comparison between de novo and in-stent restenotic lesions.
    Stankovic G; Orlic D; Di Mario C; Corvaja N; Airoldi F; Chieffo A; Amato A; Orecchia R; Colombo A
    Cardiovasc Radiat Med; 2003; 4(1):18-24. PubMed ID: 12892768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.
    Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R
    Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary brachytherapy with beta-radiation for the treatment of long diffuse in-stent restenosis.
    Schukro C; Syeda B; Schmid R; Stemberger A; Lang I; Derntl M; Neunteufl T; Christ G; Kirisits C; Pokrajac B; Glogar D
    Coron Artery Dis; 2004 Aug; 15(5):285-9. PubMed ID: 15238826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
    Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
    Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome of patients treated with beta-brachytherapy in routine clinical practice.
    Nikas DN; Kalef-Ezra J; Katsouras CS; Tsekeris P; Bozios G; Pappas C; Naka KK; Kotsia A; Papamichael N; Sideris DA; Michalis LK
    Int J Cardiol; 2007 Feb; 115(2):183-9. PubMed ID: 16890309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis.
    Lee SW; Park SW; Park DW; Lee SW; Kim SH; Jang JS; Jeong YH; Kim YH; Lee CW; Hong MK; Yun SC; Kim JJ; Park SJ
    Am J Cardiol; 2007 Aug; 100(3):425-30. PubMed ID: 17659922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic and clinical outcomes at 8 months of cutting balloon angioplasty and beta-brachytherapy for native vessel in-stent restenosis (BETACUT): results from a stopped randomized controlled trial.
    Schlüter M; Tübler T; Lansky AJ; Kähler S; Berger J; Mathey DG; Schofer J
    Catheter Cardiovasc Interv; 2005 Nov; 66(3):320-6. PubMed ID: 16216024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary brachytherapy after stenting de novo lesions in diabetic patients: results of a randomized intravascular ultrasound study.
    Sabaté M; Pimentel G; Prieto C; Corral JM; Bañuelos C; Angiolillo DJ; Alfonso F; Hernández-Antolín R; Escaned J; Fantidis P; Fernández C; Fernández-Ortiz A; Moreno R; Macaya C
    J Am Coll Cardiol; 2004 Aug; 44(3):520-7. PubMed ID: 15358014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of model of renarrowing after beta radiation for in-stent restenosis.
    Witkowski A; Chmielak Z; Kalińczuk Ł; Pregowski J; Kepka C; Kruk M; Przyłuski J; Łyczek J; Bulski W; Kawczyńska M; Kulik A; Owczarczyk J; Ruzyłło W
    Int J Cardiol; 2006 Feb; 107(2):247-53. PubMed ID: 16412805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of 32P beta brachytherapy failure in patients with high-risk in-stent restenosis.
    Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Bunkheila F; Neri S; Lombardo E; Marrozzini C; Pini S; Taglieri N; Sbarzaglia P; Reggiani ML; Barbieri E; Branzi A
    Cardiovasc Radiat Med; 2004; 5(2):77-83. PubMed ID: 15464944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.
    Kim S; Almeda FQ; Tessalee M; Snell RJ; Nathan S; Thew S; Nguyen C; Chu JC; Schaer GL
    Cardiovasc Radiat Med; 2004; 5(1):9-14. PubMed ID: 15275626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary 166Holmium brachytherapy combined with cutting balloon angioplasty for the treatment of in-stent restenosis.
    Park S; Kang WC; Rhee JH; Ko YG; Choi D; Jang Y; Lee JD; Shim WH; Cho SY
    Cardiovasc Radiat Med; 2003; 4(3):119-25. PubMed ID: 14984711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.